AstraZeneca | AZN - Ordinary Share Capital



AstraZeneca reported $1.55B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Alcon AG USD 20M 0 Mar/2025
Almirall EUR 214.79M 189.17M Jun/2025
Amgen USD 538M 33.04B Jun/2025
argenx SE 61.17M 405.3K Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Autolus Therapeutics Ltd 266.14M 266.01M Jun/2025
Bayer EUR 982.42M 1.53B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Fresenius EUR 563.24M 237K Jun/2025
Fresenius Medical Care EUR 293.41M 0 Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Genmab DKK 10M 56M Mar/2025
Gilead Sciences USD 1.24B 3M Jun/2025
GlaxoSmithKline GBP 4.15B 2.8B Jun/2025
GRIFOLS EUR 680.41M 560.8M Jun/2025
Haleon 8.98B 8.89B Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Merck EUR 434.78M 130.22M Jun/2025
Merck USD 1.79B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
Orion EUR 140.69M 48.49M Jun/2025
Pfizer USD 5.68B 5.2B Jun/2025
Philips EUR 950.57M 762.57M Jun/2025
Recordati EUR 205.56M 179.42M Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Sanofi 1.22B 36.5M Jun/2025
UCB EUR 584M 0 Dec/2024